<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="81805">
  <stage>Registered</stage>
  <submitdate>13/01/2007</submitdate>
  <approvaldate>8/02/2007</approvaldate>
  <actrnumber>ACTRN12607000114448</actrnumber>
  <trial_identification>
    <studytitle>Multisite Intervention Study on Suicidal Behaviours (SUPRE-MISS)</studytitle>
    <scientifictitle>In suicide attempters, does a brief information intervention and follow-up contact compared with treatment as usual decrease mortality rate?</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Suicidal behaviour (suicidal thoughts, attempted suicide, completed suicide)</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Suicide</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Suicide attempters seen at emergency care settings, comparison of treatment as usual (TAU) versus brief intervention and contact (BIC).                                                                                     BIC: a one-hour individual information session as close to the time of discharge as possible (including information about suicidal behaviour as a sign of psychological/social distress, risk factors and protective factors for suicidal behaviour, basic epidemiology, repetition, contacts) PLUS after discharge phone calls or visits, as appropriate, according to a time line asking how the person feels and whether he or she needs any support and referral to an appropriate channel if needed.                                                                                                                                 The time line of contacts is as follows: 1, 2, 4, 7, 11 weeks, 4, 6, 12, 18 months after discharge. </interventions>
    <comparator>TAU: according to the norms prevailing in the respective emergency department in each site. The TAU group is followed up only at 18 months after discharge.</comparator>
    <control>Active</control>
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Completed suicide (mortality)</outcome>
      <timepoint>Assessed once the intervention (brief intervention and contact) has been completed at the 18-month follow-up.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Attempted suicide (morbidity; i.e. repeated suicide attempts), other variables such as hopelessness, wellbeing, need of support, assessed once the intervention has been completed at the 18-month follow-up.</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>All suicide attempters seen at the emergencey care settings.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Death in the ward, clinical conditions not allowing an interview, leaving against medical order, residence in a different catchment area, language problems.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>An allocation sequence based on a random number table was used to randomly assign all enrolled subjects to BIC or TAU; the allocation sequence was maintained in a separate location to ensure that clinicians responsible for assignment of subjects could not bias the assignment. Allocation was concealed done by sealed opaque envelopes.</concealment>
    <sequence>An allocation sequence based on a random number table was used to randomly assign all enrolled subjects to BIC or TAU. The random order generation was done by simple randomisation by using a randomisation table from a statistic book.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Single blind - the subjects were blinded and unaware of the intervention assignment.</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/01/2002</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>1730</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Switzerland</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Charities/Societies/Foundations</primarysponsortype>
    <primarysponsorname>World Health Organization</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>World Health Organization</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Fundacao de Amparo a Pesquisa do Estado de Sao Paulo</fundingname>
      <fundingaddress />
      <fundingcountry>Brazil</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Medical Research Council</fundingname>
      <fundingaddress />
      <fundingcountry>South Africa</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Mental Health Research Centre</fundingname>
      <fundingaddress />
      <fundingcountry>Iran, Islamic Republic Of</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Estonian Health Insurance Fund</fundingname>
      <fundingaddress />
      <fundingcountry>Estonia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>Karolinska Institute</fundingname>
      <fundingaddress />
      <fundingcountry>Estonia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study evaluates the effectiveness of brief intervention and contact compared to treatment as usual for suicide attempters to reduce subsequent suicide mortality.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname> Department of Psychiatry, FCM-UNICAMP-Faculdade de Ciencias Medicas, Comite de Etica em Pesquisa, UNICAMP</ethicname>
      <ethicaddress />
      <ethicapprovaldate>19/03/2002</ethicapprovaldate>
      <hrec>WHO Registry No. M4/445/137/BRA</hrec>
      <ethicsubmitdate />
      <ethiccountry>Brazil</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Research Centre of Clinical Epidemiology, Beijing Hui Long Guan Hospital-Medical Ethics Committee, Beijing Hui Long Guan Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate>10/10/2001</ethicapprovaldate>
      <hrec>WHO Registry No. M4/445/137/CHN</hrec>
      <ethicsubmitdate />
      <ethiccountry>China</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Estonian-Swedish Institute of Suicidology-Tallinn Medical Research Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate>22/08/2001</ethicapprovaldate>
      <hrec>WHO Registry No. M4/181/170</hrec>
      <ethicsubmitdate />
      <ethiccountry>Estonia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Voluntary Health Services, Chennai-Ethics Committee of the Voluntary Health Services</ethicname>
      <ethicaddress />
      <ethicapprovaldate>11/10/2001</ethicapprovaldate>
      <hrec>WHO Registry No. M4/181/171</hrec>
      <ethicsubmitdate />
      <ethiccountry>India</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Tehran Psychiatric Institute, Iran University of Medical Sciences and Health Services-Ethics Committee of Iran University of Medical Sciences</ethicname>
      <ethicaddress />
      <ethicapprovaldate>3/09/2001</ethicapprovaldate>
      <hrec>WHO Registry No. M4/181/173</hrec>
      <ethicsubmitdate />
      <ethiccountry>Iran, Islamic Republic Of</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Tehran Psychiatric Institute, Iran University of Medical Sciences and Health Services-National Committee in Medical Research</ethicname>
      <ethicaddress />
      <ethicapprovaldate>20/10/2001</ethicapprovaldate>
      <hrec>WHO Registry No. M4/181/173</hrec>
      <ethicsubmitdate />
      <ethiccountry>Iran, Islamic Republic Of</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Department of Medically Applied Psychology, Nelson R. Mandela School of Medicine, University of Natal-Sub-Committee of Research Ethics Committee, University of Natal</ethicname>
      <ethicaddress />
      <ethicapprovaldate>30/01/2002</ethicapprovaldate>
      <hrec>WHO Registry No. M4/445/137/SOA</hrec>
      <ethicsubmitdate />
      <ethiccountry>South Africa</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Department of Psychological Medicine, Faculty of Medicine-Ethical Review Committee, Faculty Board, Medical Faculty Colombo</ethicname>
      <ethicaddress />
      <ethicapprovaldate>14/12/2001</ethicapprovaldate>
      <hrec>WHO Registry No. M4/445/137SRL</hrec>
      <ethicsubmitdate />
      <ethiccountry>Sri Lanka</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Hanoi Medical University-Ethics Committee of National Committee, Ministry of Health, Social Republic of Viet Nam</ethicname>
      <ethicaddress />
      <ethicapprovaldate>15/08/2001</ethicapprovaldate>
      <hrec>WHO Registry No. M4/181/172</hrec>
      <ethicsubmitdate />
      <ethiccountry>Viet Nam</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Alexandra Fleischmann</name>
      <address>20. avenue Appia,
CH-1211 Geneva 27</address>
      <phone>+41 22 7913444</phone>
      <fax>+41 22 7914160</fax>
      <email>fleischmanna@who.int</email>
      <country>Switzerland</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Alexandra Fleischmann</name>
      <address>20. avenue Appia,
CH-1211 Geneva 27</address>
      <phone>+41 22 7913444</phone>
      <fax>+41 22 7914160</fax>
      <email>fleischmanna@who.int</email>
      <country>Switzerland</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>